Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

Clicks: 439
ID: 112995
2000
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
An aerosolized plague weapon could cause fever, cough, chest pain, and hemoptysis with signs consistent with severe pneumonia 1 to 6 days after exposure. Rapid evolution of disease would occur in the 2 to 4 days after symptom onset and would lead to septic shock with high mortality without early tre …
Reference Key
tv2000jamaplague Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Inglesby TV;Dennis DT;Henderson DA;Bartlett JG;Ascher MS;Eitzen E;Fine AD;Friedlander AM;Hauer J;Koerner JF;Layton M;McDade J;Osterholm MT;O'Toole T;Parker G;Perl TM;Russell PK;Schoch-Spana M;Tonat K;;
Journal JAMA
Year 2000
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10807389
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't P.H.S. anti-bacterial agents / therapeutic use guideline biological warfare / prevention & control* consensus development conference t v inglesby k tonat decontamination infection control pmid:10807389 doi:10.1001/jama.283.17.2281 d t dennis civil defense disaster planning plague / epidemiology plague / physiopathology plague / prevention & control* plague vaccine violence virulence yersinia pestis* / pathogenicity

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.